Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice
Satralizumab was effective and well tolerated in patients with NMOSD, including those who switched from previous treatments due to inadequate disease control and/or intolerance. These real-world outcomes align with long-term safety and efficacy findings from the Phase III SAkura trials.
Authors
- Ahmed Z. Obeidat (ORCID: https://orcid.org/0000-0002-3549-3277)
- Ahmad Mahadeen (ORCID: https://orcid.org/0000-0002-5680-6420)
- Clifford Reed
- Yang Mao‐Draayer (ORCID: https://orcid.org/0000-0001-6248-3480)
- Dmitry Khaitov
- Jose Avila-Ornelas (ORCID: https://orcid.org/0000-0002-4528-5359)
- Mary Alissa Willis (ORCID: https://orcid.org/0000-0001-7950-7602)
- Benjamin Osborne
- Lisa Ferayorni
- Diana Vargas (ORCID: https://orcid.org/0000-0003-0668-5664)
- Negar Molazadeh (ORCID: https://orcid.org/0000-0003-0861-2178)
- William S. Baek (ORCID: https://orcid.org/0000-0003-2285-8510)
- Brian Steingo
- Michelle Tsai (ORCID: https://orcid.org/0000-0002-6914-7671)
- Adnan Subei
- Rebecca Romero (ORCID: https://orcid.org/0000-0002-1576-5597)
- Angie Kim
- Hesham Abboud (ORCID: https://orcid.org/0000-0001-5346-8254)
- Rosemarie Walch
- Robert K. Shin (ORCID: https://orcid.org/0000-0002-1313-8071)
- Buse Sengul
- Paige Goulette
- Michael Levy (ORCID: https://orcid.org/0000-0002-7969-8346)
- Krupa Pandey
- Shervin Gholizadeh (ORCID: https://orcid.org/0000-0002-5321-5393)
- Robert Pace
- Julie Patel
- Jeanie Coté
Institutions
- Lehigh Valley Hospital-Pocono (US)
- Cleveland Clinic (US)
- Hackensack University Medical Center (US)
- Ochsner Health System (US)
- Harvard University (US)
- Emory University (US)
- The University of Texas at San Antonio Health Science Center (US)
- Georgetown University (US)
- Medical College of Wisconsin (US)
- University Hospitals of Cleveland (US)
- Multiple Sclerosis Foundation (US)
- Reading Hospital (US)
- Emory University Hospital Midtown (US)
- MedStar Georgetown University Hospital (US)
- Jackson Memorial Hospital (US)
- University of Mississippi Medical Center (US)
- Oklahoma Medical Research Foundation (US)
- NYU Langone Health (US)
- Massachusetts General Hospital (US)
- Lehigh Valley Health Network (US)
- Memorial Healthcare System (US)
- Acentech (United States) (US)
- Sunrise Medical (United States) (US)
- Multiple Sclerosis Center of Atlanta (US)
- Kaiser Permanente South San Francisco Medical Center (US)
- Texas Neurology (US)
- Infinity (United States) (US)
- Parkside Hospital (GB)
- University of Virginia (US)
- New York University (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Multiple Sclerosis Journal - Experimental Translational and Clinical
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1177/20552173251386895
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00